 |
市場調查報告書
商品編碼
1635138
空間基因組學和轉錄組學市場：按產品、技術、服務類型和應用分類的 2029 年全球預測Spatial Genomics & Transcriptomics Market by Product (Instruments, Consumables, Services), Technique(Transcriptomics (IHC, ISH), Genomics (LCM)), Service Type(Sample Prep, Sequencing), Application (Translation Research (Cancer))-Global Forecast to 2029 |
||||||
價格
全球空間基因組學和轉錄組學產品市場規模預計將從 2024 年的 5.545 億美元增至 2029 年的 9.957 億美元，預測期內的複合年成長率為 12.4%。
| 研究範圍 | |
|---|---|
| 調查年份 | 2022-2029 |
| 基準年 | 2023 |
| 預測期 | 2024-2029 |
| 單元 | 美元 |
| 部分 | 產品、技術、用途、類型（服務）、最終用戶（產品）、最終用戶（服務） |
| 目標區域 | 北美、歐洲、亞太地區、拉丁美洲、中東和非洲 |
由於新產品的推出以及空間基因組學和轉錄組學在藥物發現和開發中的接受度不斷提高等因素，空間基因組學和轉錄組學市場正在不斷擴大。然而，高昂的初始資本投入、技術複雜性和知識差距給該行業帶來了挑戰。
“通過提供，該產品部門在 2023 年佔據了最大的市場佔有率。”
該產品部分在 2023 年佔據了最大佔有率。研究中對高解析度空間基因和蛋白質表現資料的需求不斷成長，有助於解釋該領域的擴展。市場擴張的關鍵促進因素是消耗品和空間基因組學/轉錄組學在藥物研發以及生物行銷人員的識別中的應用日益廣泛。此細分市場的主要成長動力是市場參與企業對開發各種軟體的投資不斷增加，尤其是用於空間分析和新產品介紹的軟體。
“從技術角度來看，空間轉錄組學技術將在 2023 年佔據最大的市場佔有率。”
由於原位定序技術的接受度不斷提高及其在疾病研究中的更全面應用，空間轉錄組學領域在 2023 年佔據了市場的最大佔有率。空間轉錄組學允許在組織的空間環境中繪製基因表現圖。將組織學與分子資料結合可以揭示基因在特定組織區域中的表現方式，從而了解細胞組織、功能和疾病進展。
“預計 2024 年至 2029 年間亞太地區的複合年成長率最高。”
預計未來幾年亞太地區的市場參與者數量將會增加，這得益於政府為應對日益成長的醫療保健需求而採取的更多行動、政府對生物技術的投資不斷增加、對精準醫療的需求不斷成長、醫療保健支出不斷增加以及法規環境不斷擴大並在印度、中國和日本等主要市場發展。同時，北美在 2023 年佔據了最大的市場佔有率。
本報告分析了全球空間基因組學和轉錄組學市場，並提供了關鍵促進因素和限制因素、競爭格局和未來趨勢的資訊。
目錄
第 1 章 簡介
第2章 研究方法
第3章執行摘要
第 4 章重要考察
- 空間基因組學和轉錄組學市場概覽
- 亞太地區空間基因組學和轉錄組學產品市場佔有率（按技術和國家分類）（2023 年）
- 空間基因組學和轉錄組學產品市場：地理成長機會
- 空間基因組學和轉錄組學產品市場佔有率（按最終用戶分類） (2023)
- 空間基因組學和轉錄組學服務市場佔有率（按最終用戶分類）（2023 年）
第5章 市場概況
- 介紹
- 市場動態
- 驅動程式
- 限制因素
- 機會
- 任務
- 影響客戶業務的趨勢/干擾
- 定價分析
- 主要企業設備平均售價趨勢（2021-2023年）
- 主要企業消耗品平均售價趨勢（2021-2023年）
- 各地區主要產品平均售價（2021-2023年）
- 供應鏈分析
- 價值鏈分析
- 生態系分析
- 技術分析
- 關鍵技術
- 互補技術
- 相關技術
- 專利分析
- 重大會議和活動（2025-2026年）
- 監管格局
- 監管機構、政府機構和其他組織
- 法規結構
- 波特五力分析
- 主要相關利益者和採購標準
- 貿易分析
- HS 編碼 902790 的進口資料
- HS 編碼 902790 的出口資料
- 投資金籌措場景
- 人工智慧/生成式人工智慧對空間基因組學和轉錄組學市場的影響
6. 空間基因體學及轉錄組學市場依產品分類
- 介紹
- 產品
- 設備和軟體
- 耗材
- 服務
7. 空間基因體學和轉錄組學產品市場（按技術）
- 介紹
- 空間轉錄組學
- 免疫組織化學
- 螢光
- 基於顯微鏡的 RNA 成像
- 原位雜合反應
- 雷射捕獲晶粒
- RNA定序
- 其他空間轉錄組學技術
- 空間基因體學
- 原位雜合反應
- 雷射捕獲晶粒
- 基因測序
- 其他空間基因體學技術
8. 空間基因體學和轉錄組學服務市場（按類型）
- 介紹
- 樣品製備服務
- 定序和分析服務
- 資料視覺化和分析服務
9. 空間基因體學和轉錄組學市場（按應用）
- 介紹
- 翻譯研究
- 癌症
- 免疫學
- 神經科學
- 感染疾病
- 其他疾病
- 藥物研發
10. 空間基因體學和轉錄組學產品市場（按最終用戶）
- 介紹
- 製藥和生物技術公司
- 學術研究所
- CRO 和 CDMO
- 臨床診斷實驗室
第 11 章。
- 介紹
- 製藥和生物技術公司
- 學術研究所
- 其他最終用戶
12. 空間基因體學和轉錄組學市場（按地區）
- 介紹
- 北美洲
- 北美宏觀經濟展望
- 美國
- 加拿大
- 歐洲
- 歐洲宏觀經濟展望
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
- 亞太地區
- 亞太宏觀經濟展望
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 其他亞太地區
- 拉丁美洲
- 拉丁美洲宏觀經濟展望
- 巴西
- 墨西哥
- 其他拉丁美洲國家
- 中東
- 非洲
第13章 競爭格局
- 介紹
- 主要參與企業的策略/優勢
- 收益分析（2019-2023）
- 市場佔有率分析（2023 年）
- 空間基因組學和轉錄組學產品市場
- 空間基因組學和轉錄組學服務市場
- 主要市場公司排名
- 公司估值和財務指標
- 品牌/產品比較
- 企業評等矩陣：主要企業（2023 年）
- 公司評估矩陣：Start-Ups/中小企業（2023 年）
- 競爭場景
第14章 公司簡介
- 主要企業
- 10X GENOMICS
- BIO-TECHNE
- NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.)
- STANDARD BIOTOOLS
- ILLUMINA, INC.
- BIO-RAD LABORATORIES, INC.
- AKOYA BIOSCIENCES, INC.
- VISIOPHARM A/S
- DANAHER CORPORATION
- SEVEN BRIDGES GENOMICS
- REVVITY
- VIZGEN INC.
- VERACYTE, INC.
- NATERA, INC.
- MACROGEN INC.
- MILTENYI BIOTEC
- 其他公司
- BIOMARKER TECHNOLOGIES (BMKGENE)
- ULTIVUE, INC.
- RARECYTE, INC.
- S2 GENOMICS, INC.
- ADMERA HEALTH
- SONY BIOTECHNOLOGY INC.
- CANTATA BIO
- NUCLEAI, INC.
- VISIKOL, INC.
- IONPATH, INC.
- BIOSPYDER, INC.
- SINGULAR GENOMICS SYSTEMS, INC.
- LUNAPHORE TECHNOLOGIES SA
- REBUS BIOSYSTEMS, INC.
第15章 附錄
Product Code: BT 7790
The spatial genomics & transcriptomics product market is expected to reach USD 995.7 million in 2029 from USD 554.5 million in 2024, at a CAGR of 12.4% during the forecast period.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2022-2029 |
| Base Year | 2023 |
| Forecast Period | 2024-2029 |
| Units Considered | Value (USD) |
| Segments | Offering, Technique, Application, Type (Service), End User (Product), End User (Service) |
| Regions covered | North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
The spatial genomics and transcriptomics market is expanding under the influence of factors like new product introduction and rising acceptance of spatial genomics and transcriptomics in medication discovery and development. Nevertheless, expensive initial capital inputs and technical complexity and knowledge gap create various difficulties for the industry.
"The product segment accounted for the largest share by offering segment in the spatial genomics & transcriptomics market in 2023".
Products and services divide the spatial genomics & transcriptomics market. In 2023 the product segment held the biggest share. The growing demand for high-resolution spatial gene and protein expression data in research helps to explain the expansion of this area. The main forces behind the market expansion are the expanding uses of consumables and spatial genomics and transcriptomics in drug research and development as well as biomarketer identification. Key element driving development in this market segment is increased investments by market participants in creating various software especially for spatial analysis and introduction of new goods.
"The spatial transcriptomics technique held the highest market share of the spatial genomics and transcriptomics market by technique in 2023".
Techniques divide the spatial genomics and transcriptomics market into spatial transcriptomics and spatial genomics segments. Driven by growing acceptance of in situ sequencing technologies and more general applications in disease research, the segment of spatial transcriptomics held the biggest share of spatial genomics & transcriptomics market in 2023. Using spatial transcriptomics, one may map gene expression inside the spatial context of a tissue. Combining histology and molecular data reveals how genes are expressed in certain tissue country or region, so providing understanding of cellular organization, function, and disease progression.
"The Asia Pacific region is growing at the highest CAGR in the spatial genomics & transcriptomics market from 2024 to 2029."
The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the a
increasing government efforts to rising healthcare needs, growing government investment in
biotechnology, growing demand of precision medicine, rising healthcare expenditure, growing
R&D expansion in key markets such as India, China, and Japan, and the favorable regulatory
environment in the region. However, North America held the largest share of spatial genomics & transcriptomics market in 2023.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 60% and Demand Side 40%
- By Designation: Managers - 45% CXOs and Director-level - 30%, and Executives - 25%,
- By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5%, and Middle East -5%.
List of Companies Profiled in the Report:
- NanoString Technologies, Inc. (Bruker Spatial Biology, Inc.) (US)
- 10x Genomics (US)
- Bio-Rad Laboratories, Inc. (US)
- Illumina, Inc. (US)
- Bio-Techne (US)
- Seven Bridges Genomics (US)
- Rarecyte, Inc. (US)
- Standard BioTools (US)
- Revvity (US)
- Akoya Biosciences, Inc. (US)
- Natera, Inc. (US)
- VisioPharm A/S (Switzerland)
- Danaher Corporation (US)
- Veracyte, Inc. (US)
- Biomarker Technologies (BMKGENE) (China)
- Macrogen, Inc. (South Korea)
- Miltenyi Biotec (Germany)
- Sony Biotechnology Inc. (US)
- Vizgen Inc. (US)
- BioSpyder, Inc. (US)
- Ionpath, Inc. (US)
- S2 Genomics, Inc. (US)
- Ultivue, Inc. (US)
- Admera Health (US)
- Lunaphore Technologies SA (US)
- Visikol, Inc. (US)
- Rebus Biosystems, Inc. (US)
- Singular Genomics Systems, Inc. (US)
- Cantata Bio (US)
- Nucleai, Inc. (Israel)
Research Coverage:
This research report categorizes the spatial genomics & transcriptomics market by offering (products and services), by technique (spatial transcriptomics and spatial genomics), by type (service) (sample preparation services, sequencing & analytical services, and data visualization & analysis services), by application (translational research and drug discovery & development), by end user (product) (pharmaceutical & biotechnology companies, academic & research institutes, CROs & CDMOs, and clinical diagnostic laboratories), by end user (service) (pharmaceutical & biotechnology companies, academic & research institutes, and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the spatial genomics & transcriptomics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product & service portfolio, key strategies such as product & service launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the spatial genomics & transcriptomics market. Competitive analysis of top players and upcoming startups in the spatial genomics & transcriptomics market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall spatial genomics & transcriptomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (Increasing adoption of spatial genomics and transcriptomics in drug discovery and development, Introduction of novel products, Increasing pharmaceutical R&D investments and public-private funding), restraints (High initial capital investments and maintenance costs, Technical complexity and expertise gap), opportunities (Increasing use of spatial omics for biomarker identification, Increasing demand for precision medicines and targeted drug development), and challenges (Dearth of skilled professionals) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched product/services of the spatial genomics & transcriptomics market
- Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the spatial genomics & transcriptomics market
- Competitive Assessment: NanoString Technologies, Inc. (Bruker Spatial Biology, Inc.) (US), 10x Genomics (US), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), Bio-Techne (US), Seven Bridges Genomics (US), Rarecyte, Inc. (US), Standard BioTools (US), Revvity (US), Akoya Biosciences, Inc. (US), Natera, Inc. (US), VisioPharm A/S (Switzerland), Danaher Corporation (US), Veracyte, Inc. (US), Biomarker Technologies (BMKGENE) (China), Macrogen, Inc. (South Korea), Miltenyi Biotec (Germany), Sony Biotechnology Inc. (US), Vizgen Inc. (US), BioSpyder, Inc. (US), Ionpath, Inc. (US), S2 Genomics, Inc. (US), Ultivue, Inc. (US), Admera Health (US), Lunaphore Technologies SA (US), Visikol, Inc. (US), Rebus Biosystems, Inc. (US), Singular Genomics Systems, Inc. (US), Cantata Bio (US), and Nucleai, Inc. (Israel).
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 INCLUSIONS & EXCLUSIONS
- 1.4 STUDY SCOPE
- 1.4.1 SEGMENTS AND REGIONS CONSIDERED
- 1.4.2 YEARS CONSIDERED
- 1.4.3 CURRENCY CONSIDERED
- 1.5 STAKEHOLDERS
- 1.6 SUMMARY OF CHANGES
- 1.6.1 IMPACT OF AI/GEN AI
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.1.1 Objectives of secondary research
- 2.1.2 PRIMARY DATA
- 2.1.2.1 Breakdown of primaries
- 2.1.2.2 Objectives of primary research
- 2.1.1 SECONDARY DATA
- 2.2 MARKET SIZE ESTIMATION
- 2.2.1 REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH)
- 2.2.1.1 Insights from primary sources
- 2.2.2 SEGMENTAL MARKET ESTIMATION: TOP-DOWN APPROACH (PRODUCT)
- 2.2.1 REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH)
- 2.3 GROWTH RATE PROJECTIONS
- 2.4 DATA TRIANGULATION
- 2.5 STUDY ASSUMPTIONS
- 2.6 RESEARCH LIMITATIONS
- 2.7 RISK ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET OVERVIEW
- 4.2 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET SHARE, BY TECHNIQUE AND COUNTRY (2023)
- 4.3 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- 4.4 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET SHARE, BY END USER (2023)
- 4.5 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET SHARE, BY END USER (2023)
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Increasing adoption of spatial genomics and transcriptomics in drug discovery and development
- 5.2.1.2 Introduction of novel products
- 5.2.1.3 Increasing pharmaceutical R&D investments and public-private funding
- 5.2.2 RESTRAINTS
- 5.2.2.1 High initial capital investments and maintenance costs
- 5.2.2.2 Technical complexity and expertise gap
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Increasing use of spatial omics for biomarker identification
- 5.2.3.2 Growing demand for precision medicines and targeted drug development
- 5.2.4 CHALLENGES
- 5.2.4.1 Dearth of skilled professionals
- 5.2.1 DRIVERS
- 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
- 5.4 PRICING ANALYSIS
- 5.4.1 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2021-2023
- 5.4.2 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2021-2023
- 5.4.3 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2021-2023
- 5.5 SUPPLY CHAIN ANALYSIS
- 5.6 VALUE CHAIN ANALYSIS
- 5.7 ECOSYSTEM ANALYSIS
- 5.8 TECHNOLOGY ANALYSIS
- 5.8.1 KEY TECHNOLOGIES
- 5.8.1.1 In-situ sequencing
- 5.8.1.2 In-situ hybridization
- 5.8.1.3 Single-cell RNA sequencing
- 5.8.2 COMPLEMENTARY TECHNOLOGIES
- 5.8.2.1 Multi-isotope imaging mass spectrometry
- 5.8.2.2 Spatial heatmap
- 5.8.2.3 Differential gene expression analysis
- 5.8.3 ADJACENT TECHNOLOGIES
- 5.8.3.1 Multi-omics
- 5.8.3.2 Metabolomics
- 5.8.3.3 Single-cell analysis
- 5.8.1 KEY TECHNOLOGIES
- 5.9 PATENT ANALYSIS
- 5.10 KEY CONFERENCES & EVENTS, 2025-2026
- 5.11 REGULATORY LANDSCAPE
- 5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.11.2 REGULATORY FRAMEWORK
- 5.12 PORTER'S FIVE FORCES ANALYSIS
- 5.12.1 THREAT OF NEW ENTRANTS
- 5.12.2 THREAT OF SUBSTITUTES
- 5.12.3 BARGAINING POWER OF BUYERS
- 5.12.4 BARGAINING POWER OF SUPPLIERS
- 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.13.2 KEY BUYING CRITERIA, BY END USER (PRODUCT)
- 5.14 TRADE ANALYSIS
- 5.14.1 IMPORT DATA FOR HS CODE 902790
- 5.14.2 EXPORT DATA FOR HS CODE 902790
- 5.15 INVESTMENT & FUNDING SCENARIO
- 5.16 IMPACT OF AI/GEN AI ON SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
6 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING
- 6.1 INTRODUCTION
- 6.2 PRODUCTS
- 6.2.1 INSTRUMENTS & SOFTWARE
- 6.2.1.1 Instruments & software to facilitate disease research by enabling detailed spatial mapping and multi-omic analyses
- 6.2.2 CONSUMABLES
- 6.2.2.1 Better reproducible and high-quality data collection to advance spatial genomics research in oncology and precision medicine
- 6.2.1 INSTRUMENTS & SOFTWARE
- 6.3 SERVICES
- 6.3.1 INCREASING DEMAND FOR HIGH-QUALITY SPATIAL DATA IN PRECISION MEDICINE TO AUGMENT MARKET GROWTH
7 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE
- 7.1 INTRODUCTION
- 7.2 SPATIAL TRANSCRIPTOMICS
- 7.2.1 IMMUNOHISTOCHEMISTRY
- 7.2.1.1 Increasing applications in biomarker discovery and cellular interactions within tissue architecture to drive segment
- 7.2.2 IMMUNOFLUORESCENCE
- 7.2.2.1 Advanced profiling immune-tumor microenvironments for cancer diagnosis and prognosis to propel segment growth
- 7.2.3 MICROSCOPY-BASED RNA IMAGING
- 7.2.3.1 Better insights into molecular communication within tissue architecture to augment segment growth
- 7.2.4 IN-SITU HYBRIDIZATION
- 7.2.4.1 High-throughput and 3D spatial gene expression analysis in cancer research and developmental biology to drive segment
- 7.2.5 LASER CAPTURE MICRODISSECTION
- 7.2.5.1 Analysis of gene expression data from defined cellular populations to facilitate spatial mapping within tissue sections
- 7.2.6 RNA SEQUENCING
- 7.2.6.1 In-situ RNA sequencing
- 7.2.6.1.1 Integration of ISS with bioinformatics toolkits for data analysis to facilitate interpretation of complex datasets
- 7.2.6.2 Single-cell RNA (SC-RNA) sequencing
- 7.2.6.2.1 Increasing commercial availability of scRNA-seq platforms and advancements in bioinformatics tools to drive segment
- 7.2.6.3 Other RNA sequencing
- 7.2.6.1 In-situ RNA sequencing
- 7.2.7 OTHER SPATIAL TRANSCRIPTOMIC TECHNIQUES
- 7.2.1 IMMUNOHISTOCHEMISTRY
- 7.3 SPATIAL GENOMICS
- 7.3.1 IN-SITU HYBRIDIZATION
- 7.3.1.1 Demand for high-specificity detection platforms to fuel market growth
- 7.3.2 LASER CAPTURE MICRODISSECTION
- 7.3.2.1 Detailed insights into cellular mechanisms and molecular profiles within heterogeneous tissue samples to drive segment
- 7.3.3 GENOMIC SEQUENCING
- 7.3.3.1 Microdissection-based sequencing
- 7.3.3.1.1 Increased demand for precision medicines to boost segment growth
- 7.3.3.2 Chromatin accessibility sequencing
- 7.3.3.2.1 Need for insights into gene regulation and epigenetic modifications to aid segment growth
- 7.3.3.3 Other genomic sequencing
- 7.3.3.1 Microdissection-based sequencing
- 7.3.4 OTHER SPATIAL GENOMIC TECHNIQUES
- 7.3.1 IN-SITU HYBRIDIZATION
8 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE
- 8.1 INTRODUCTION
- 8.2 SAMPLE PREPARATION SERVICES
- 8.2.1 NEED FOR ACCURATE SPATIAL ANALYSIS OF GENE EXPRESSION WITHIN TISSUE SAMPLES TO SPUR MARKET GROWTH
- 8.3 SEQUENCING & ANALYTICAL SERVICES
- 8.3.1 SEQUENCING & ANALYTICAL SERVICES TO UTILIZE ADVANCED TECHNOLOGIES FOR SEQUENCING AND BIOINFORMATICS ANALYSIS
- 8.4 DATA VISUALIZATION & ANALYSIS SERVICES
- 8.4.1 INCREASED DEMAND FOR ADVANCED TOOLS FOR COMPLEX SPATIAL GENOMICS DATA INTERPRETATION TO SUPPORT MARKET GROWTH
9 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION
- 9.1 INTRODUCTION
- 9.2 TRANSLATIONAL RESEARCH
- 9.2.1 CANCER
- 9.2.1.1 Spatial genomics and transcriptomics to map precise locations of DNA and RNA within tumor tissues in cancer research
- 9.2.2 IMMUNOLOGY
- 9.2.2.1 Need for better understanding of immune cell interactions and tissue-specific immune responses to propel segment growth
- 9.2.3 NEUROSCIENCE
- 9.2.3.1 Increased focus on mapping cellular diversity for analyzing brain function and dysfunction to aid market growth
- 9.2.4 INFECTIOUS DISEASES
- 9.2.4.1 Need for enhanced understanding of pathogen-host interactions at tissue level to drive adoption
- 9.2.5 OTHER DISEASES
- 9.2.1 CANCER
- 9.3 DRUG DISCOVERY & DEVELOPMENT
- 9.3.1 RISING USE OF RNA-SEQ IN DISEASE MANAGEMENT DRUG DISCOVERY TO DRIVE MARKET
10 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER
- 10.1 INTRODUCTION
- 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 10.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO TRANSFORM DISEASE RESEARCH AND STREAMLINE DRUG TARGET VALIDATION
- 10.3 ACADEMIC & RESEARCH INSTITUTES
- 10.3.1 FOCUS ON FOUNDATIONAL DISCOVERIES AND CELLULAR INSIGHTS ABOUT COMPLEX BIOLOGICAL SYSTEMS TO AID MARKET GROWTH
- 10.4 CROS & CDMOS
- 10.4.1 GROWING DEMAND FOR PRECISE SPATIAL MOLECULAR INSIGHTS TO PROPEL MARKET GROWTH
- 10.5 CLINICAL DIAGNOSTIC LABORATRIES
- 10.5.1 IMPROVED DIAGNOSTIC ACCURACY IN PATHOGEN DETECTION AND GENOMIC ANALYSIS TO AID MARKET GROWTH
11 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER
- 11.1 INTRODUCTION
- 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 11.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO OPTIMIZE BIOMARKER DEVELOPMENT AND IMPROVE CLINICAL TRIAL DESIGN
- 11.3 ACADEMIC & RESEARCH INSTITUTES
- 11.3.1 NEED FOR TOOLS FOR MAPPING CELLULAR ENVIRONMENTS AND STUDYING DISEASE MECHANISMS TO PROPEL MARKET GROWTH
- 11.4 OTHER END USERS
12 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY REGION
- 12.1 INTRODUCTION
- 12.2 NORTH AMERICA
- 12.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
- 12.2.2 US
- 12.2.2.1 US to dominate North American spatial genomics & transcriptomics market during forecast period
- 12.2.3 CANADA
- 12.2.3.1 Favorable government initiatives and high incidence of infectious diseases to support market growth
- 12.3 EUROPE
- 12.3.1 EUROPE: MACROECONOMIC OUTLOOK
- 12.3.2 GERMANY
- 12.3.2.1 Advanced genomics research and presence of several key companies to spur market growth
- 12.3.3 UK
- 12.3.3.1 Increasing government funding and rising demand for new diagnostic biomarkers to aid market growth
- 12.3.4 FRANCE
- 12.3.4.1 Increasing investments in life science R&D and rising number of biotech companies to propel market growth
- 12.3.5 ITALY
- 12.3.5.1 Increasing focus on neuroscience and rare disease research to augment market growth
- 12.3.6 SPAIN
- 12.3.6.1 Focus on advanced cancer research and increased need for personalized medicines to propel market growth
- 12.3.7 REST OF EUROPE
- 12.4 ASIA PACIFIC
- 12.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
- 12.4.2 CHINA
- 12.4.2.1 Increasing R&D spending by government and biopharma companies to propel market growth
- 12.4.3 JAPAN
- 12.4.3.1 Favorable government policies and high R&D funding to boost market growth
- 12.4.4 INDIA
- 12.4.4.1 Increasing collaborations between hospitals and diagnostics centers to boost market growth
- 12.4.5 SOUTH KOREA
- 12.4.5.1 Increased research on advanced precision medicines and well-established biotechnology infrastructure to aid market growth
- 12.4.6 AUSTRALIA
- 12.4.6.1 Strategic focus on advancing cancer research and precision oncology to boost market growth
- 12.4.7 REST OF ASIA PACIFIC
- 12.5 LATIN AMERICA
- 12.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
- 12.5.2 BRAZIL
- 12.5.2.1 Increasing adoption of biomarkers for drug discovery & development to drive market
- 12.5.3 MEXICO
- 12.5.3.1 Favorable funding scenario in biotechnology sector and high funding in biomanufacturing to augment market growth
- 12.5.4 REST OF LATIN AMERICA
- 12.6 MIDDLE EAST
- 12.6.1 LOWER R&D INVESTMENTS AND WEAK INFRASTRUCTURAL DEVELOPMENTS TO HINDER MARKET GROWTH
- 12.6.2 MIDDLE EAST: MACROECONOMIC OUTLOOK
- 12.7 AFRICA
- 12.7.1 INCREASING FUNDING AND PARTNERSHIPS IN RESEARCH SECTOR TO SUPPORT GROWTH OF BIOTECHNOLOGY INDUSTRY
- 12.7.2 AFRICA: MACROECONOMIC OUTLOOK
13 COMPETITIVE LANDSCAPE
- 13.1 INTRODUCTION
- 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
- 13.3 REVENUE ANALYSIS, 2019-2023
- 13.4 MARKET SHARE ANALYSIS, 2023
- 13.4.1 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET
- 13.4.2 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET
- 13.4.3 RANKING OF KEY MARKET PLAYERS
- 13.5 COMPANY VALUATION & FINANCIAL METRICS
- 13.5.1 COMPANY VALUATION
- 13.5.2 FINANCIAL METRICS
- 13.6 BRAND/PRODUCT COMPARISON
- 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 13.7.1 STARS
- 13.7.2 EMERGING LEADERS
- 13.7.3 PERVASIVE PLAYERS
- 13.7.4 PARTICIPANTS
- 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
- 13.7.5.1 Company footprint
- 13.7.5.2 Region footprint
- 13.7.5.3 Offering footprint
- 13.7.5.4 Technique footprint
- 13.7.5.5 Application footprint
- 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 13.8.1 PROGRESSIVE COMPANIES
- 13.8.2 RESPONSIVE COMPANIES
- 13.8.3 DYNAMIC COMPANIES
- 13.8.4 STARTING BLOCKS
- 13.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
- 13.8.5.1 Detailed list of key startups/SMEs
- 13.8.5.2 Competitive benchmarking of key startups/SMEs
- 13.9 COMPETITIVE SCENARIO
- 13.9.1 PRODUCT LAUNCHES
- 13.9.2 DEALS
- 13.9.3 EXPANSIONS
14 COMPANY PROFILES
- 14.1 KEY PLAYERS
- 14.1.1 10X GENOMICS
- 14.1.1.1 Business overview
- 14.1.1.2 Products/Services/Solutions offered
- 14.1.1.3 Recent developments
- 14.1.1.3.1 Product launches
- 14.1.1.3.2 Deals
- 14.1.1.3.3 Expansions
- 14.1.1.4 MnM view
- 14.1.1.4.1 Key strengths
- 14.1.1.4.2 Strategic choices
- 14.1.1.4.3 Weaknesses and competitive threats
- 14.1.2 BIO-TECHNE
- 14.1.2.1 Business overview
- 14.1.2.2 Products/Services/Solutions offered
- 14.1.2.3 Recent developments
- 14.1.2.3.1 Product launches
- 14.1.2.3.2 Deals
- 14.1.2.3.3 Expansions
- 14.1.2.4 MnM view
- 14.1.2.4.1 Key strengths
- 14.1.2.4.2 Strategic choices
- 14.1.2.4.3 Weaknesses and competitive threats
- 14.1.3 NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.)
- 14.1.3.1 Business overview
- 14.1.3.2 Products/Services/Solutions offered
- 14.1.3.3 Recent developments
- 14.1.3.3.1 Product launches
- 14.1.3.3.2 Deals
- 14.1.3.4 MnM view
- 14.1.3.4.1 Key strengths
- 14.1.3.4.2 Strategic choices
- 14.1.3.4.3 Weaknesses and competitive threats
- 14.1.4 STANDARD BIOTOOLS
- 14.1.4.1 Business overview
- 14.1.4.2 Products/Services/Solutions offered
- 14.1.4.3 Recent developments
- 14.1.4.3.1 Product launches
- 14.1.4.3.2 Deals
- 14.1.4.4 MnM view
- 14.1.4.4.1 Key strengths
- 14.1.4.4.2 Strategic choices
- 14.1.4.4.3 Weaknesses and competitive threats
- 14.1.5 ILLUMINA, INC.
- 14.1.5.1 Business overview
- 14.1.5.2 Products/Services/Solutions offered
- 14.1.5.3 Recent developments
- 14.1.5.3.1 Product launches
- 14.1.5.3.2 Deals
- 14.1.5.4 MnM view
- 14.1.5.4.1 Key strengths
- 14.1.5.4.2 Strategic choices
- 14.1.5.4.3 Weaknesses and competitive threats
- 14.1.6 BIO-RAD LABORATORIES, INC.
- 14.1.6.1 Business overview
- 14.1.6.2 Products/Services/Solutions offered
- 14.1.6.3 Recent developments
- 14.1.6.3.1 Product launches
- 14.1.6.3.2 Deals
- 14.1.7 AKOYA BIOSCIENCES, INC.
- 14.1.7.1 Business overview
- 14.1.7.2 Products/Services/Solutions offered
- 14.1.7.3 Recent developments
- 14.1.7.3.1 Product launches
- 14.1.7.3.2 Deals
- 14.1.7.3.3 Expansions
- 14.1.8 VISIOPHARM A/S
- 14.1.8.1 Business overview
- 14.1.8.2 Products/Services/Solutions offered
- 14.1.8.3 Recent developments
- 14.1.8.3.1 Product launches
- 14.1.8.3.2 Deals
- 14.1.9 DANAHER CORPORATION
- 14.1.9.1 Business overview
- 14.1.9.2 Products/Services/Solutions offered
- 14.1.9.3 Recent developments
- 14.1.9.3.1 Deals
- 14.1.10 SEVEN BRIDGES GENOMICS
- 14.1.10.1 Business overview
- 14.1.10.2 Products/Services/Solutions offered
- 14.1.10.3 Recent developments
- 14.1.10.3.1 Deals
- 14.1.11 REVVITY
- 14.1.11.1 Business overview
- 14.1.11.2 Products/Services/Solutions offered
- 14.1.11.3 Recent developments
- 14.1.11.3.1 Product launches & approvals
- 14.1.11.3.2 Deals
- 14.1.12 VIZGEN INC.
- 14.1.12.1 Business overview
- 14.1.12.2 Products/Services/Solutions offered
- 14.1.12.3 Recent developments
- 14.1.12.3.1 Product launches
- 14.1.12.3.2 Deals
- 14.1.13 VERACYTE, INC.
- 14.1.13.1 Business overview
- 14.1.13.2 Products/Services/Solutions offered
- 14.1.14 NATERA, INC.
- 14.1.14.1 Business overview
- 14.1.14.2 Products/Services/Solutions offered
- 14.1.14.3 Recent developments
- 14.1.14.3.1 Product launches
- 14.1.14.3.2 Expansions
- 14.1.15 MACROGEN INC.
- 14.1.15.1 Business overview
- 14.1.15.2 Products/Services/Solutions offered
- 14.1.15.3 Recent developments
- 14.1.15.3.1 Deals
- 14.1.16 MILTENYI BIOTEC
- 14.1.16.1 Business overview
- 14.1.16.2 Products/Services/Solutions offered
- 14.1.16.3 Recent developments
- 14.1.16.3.1 Deals
- 14.1.1 10X GENOMICS
- 14.2 OTHER PLAYERS
- 14.2.1 BIOMARKER TECHNOLOGIES (BMKGENE)
- 14.2.2 ULTIVUE, INC.
- 14.2.3 RARECYTE, INC.
- 14.2.4 S2 GENOMICS, INC.
- 14.2.5 ADMERA HEALTH
- 14.2.6 SONY BIOTECHNOLOGY INC.
- 14.2.7 CANTATA BIO
- 14.2.8 NUCLEAI, INC.
- 14.2.9 VISIKOL, INC.
- 14.2.10 IONPATH, INC.
- 14.2.11 BIOSPYDER, INC.
- 14.2.12 SINGULAR GENOMICS SYSTEMS, INC.
- 14.2.13 LUNAPHORE TECHNOLOGIES SA
- 14.2.14 REBUS BIOSYSTEMS, INC.
15 APPENDIX
- 15.1 DISCUSSION GUIDE
- 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 15.3 CUSTOMIZATION OPTIONS
- 15.4 RELATED REPORTS
- 15.5 AUTHOR DETAILS
List of Tables
- TABLE 1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: INCLUSIONS & EXCLUSIONS
- TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
- TABLE 3 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: RISK ANALYSIS
- TABLE 4 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS
- TABLE 5 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2021-2023 (USD)
- TABLE 6 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2021-2023 (USD)
- TABLE 7 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2023 (USD)
- TABLE 8 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2022 (USD)
- TABLE 9 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2021 (USD)
- TABLE 10 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: ROLE IN ECOSYSTEM
- TABLE 11 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2021-2023
- TABLE 12 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
- TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 16 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 17 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: REGULATORY SCENARIO, BY COUNTRY
- TABLE 18 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PORTER'S FIVE FORCES
- TABLE 19 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
- TABLE 20 KEY BUYING CRITERIA, BY END USER (PRODUCT)
- TABLE 21 IMPORT DATA FOR HS CODE 902790, BY COUNTRY, 2021-2022 (USD MILLION)
- TABLE 22 EXPORT DATA FOR HS CODE 902790, BY COUNTRY, 2021-2022 (USD MILLION)
- TABLE 23 IMMUNOFLUORESCENCE QUANTITATIVE ANALYZERS IMPORT/EXPORT DATA, MARCH 2023-FEBRUARY 2024
- TABLE 24 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 25 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 26 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY VOLUME, 2022-2029 (UNITS)
- TABLE 27 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 28 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 29 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 30 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 31 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 32 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY REGION, 2022-2029 (USD MILLION)
- TABLE 33 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 34 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 35 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 36 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 37 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 38 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 39 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 40 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 41 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 42 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 43 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 44 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 45 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 46 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 47 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 48 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 49 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 50 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 51 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 52 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 53 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 54 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2022-2029 (USD MILLION)
- TABLE 55 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 56 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 57 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 58 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 59 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY REGION, 2022-2029 (USD MILLION)
- TABLE 60 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 61 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 62 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 63 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 64 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 65 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 66 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 67 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 68 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR MICROSCOPY-BASED RNA IMAGING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 69 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY REGION, 2022-2029 (USD MILLION)
- TABLE 70 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 71 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 72 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 73 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 74 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY REGION, 2022-2029 (USD MILLION)
- TABLE 75 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 76 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 77 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 78 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 79 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 80 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 81 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 82 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 83 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 84 IN-SITU RNA SEQUENCING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 85 NORTH AMERICA: IN-SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 86 EUROPE: IN-SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 87 ASIA PACIFIC: IN-SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 88 LATIN AMERICA: IN-SITU RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 89 SINGLE-CELL RNA (SC-RNA) SEQUENCING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 90 NORTH AMERICA: SINGLE-CELL RNA (SC-RNA) SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 91 EUROPE: SINGLE-CELL RNA (SC-RNA) SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 92 ASIA PACIFIC: SINGLE-CELL RNA (SC-RNA) SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 93 LATIN AMERICA: SINGLE-CELL RNA (SC-RNA) SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 94 OTHER RNA SEQUENCING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 95 NORTH AMERICA: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 96 EUROPE: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 97 ASIA PACIFIC: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 98 LATIN AMERICA: OTHER RNA SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 99 SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER TRANSCRIPTOMICS TECHNIQUES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 100 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 101 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 102 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 103 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR OTHER TRANSCRIPTOMICS TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 104 SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 105 SPATIAL GENOMICS PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 106 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 107 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 108 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 109 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 110 SPATIAL GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY REGION, 2022-2029 (USD MILLION)
- TABLE 111 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 112 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 113 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 114 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR IN-SITU HYBRIDIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 115 SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY REGION, 2022-2029 (USD MILLION)
- TABLE 116 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 117 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 118 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 119 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR LASER CAPTURE MICRODISSECTION, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 120 SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 121 SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 122 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 123 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 124 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 125 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 126 MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 127 NORTH AMERICA: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 128 EUROPE: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 129 ASIA PACIFIC: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 130 LATIN AMERICA: MICRODISSECTION-BASED SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 131 CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 132 NORTH AMERICA: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 133 EUROPE: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 134 ASIA PACIFIC: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 135 LATIN AMERICA: CHROMATIN ACCESSIBILITY SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 136 OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 137 NORTH AMERICA: OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 138 EUROPE: OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 139 ASIA PACIFIC: OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 140 LATIN AMERICA: OTHER GENOMIC SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 141 SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMIC TECHNIQUES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 142 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMIC TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 143 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMIC TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 144 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMIC TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 145 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR OTHER SPATIAL GENOMIC TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 146 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 147 SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 148 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 149 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 150 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 151 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 152 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEQUENCING & ANALYTICAL SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 153 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 154 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 155 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 156 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEQUENCING & ANALYTICAL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 157 SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 158 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 159 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 160 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 161 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS DATA VISUALIZATION & ANALYSIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 162 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 163 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 164 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY REGION, 2022-2029 (USD MILLION)
- TABLE 165 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 166 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 167 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 168 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 169 TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY REGION, 2022-2029 (USD MILLION)
- TABLE 170 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 171 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 172 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 173 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 174 TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY REGION, 2022-2029 (USD MILLION)
- TABLE 175 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 176 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 177 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 178 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 179 TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY REGION, 2022-2029 (USD MILLION)
- TABLE 180 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 181 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 182 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 183 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR NEUROSCIENCE, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 184 TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 185 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 186 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 187 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 188 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 189 TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 190 NORTH AMERICA: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 191 EUROPE: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 192 ASIA PACIFIC: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 193 LATIN AMERICA: TRANSLATIONAL RESEARCH MARKET FOR OTHER DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 194 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022-2029 (USD MILLION)
- TABLE 195 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 196 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 197 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 198 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 199 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 200 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 201 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 202 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 203 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 204 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 205 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 206 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 207 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 208 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 209 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 210 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 211 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 212 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 213 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 214 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 215 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 216 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 217 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 218 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 219 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 220 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 221 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 222 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 223 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 224 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 225 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 226 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 227 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 228 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 229 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 230 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 231 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 232 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 233 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 234 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 235 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 236 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 237 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 238 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 239 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 240 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 241 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 242 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 243 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 244 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 245 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 246 NORTH AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 247 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 248 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 249 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 250 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 251 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 252 NORTH AMERICA: KEY MACROINDICATORS
- TABLE 253 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 254 US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 255 US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 256 US: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 257 US: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 258 US: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 259 US: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 260 US: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 261 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 262 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 263 US: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 264 US: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 265 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 266 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 267 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 268 CANADA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 269 CANADA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 270 CANADA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 271 CANADA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 272 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 273 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 274 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 275 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 276 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 277 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 278 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 279 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 280 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 281 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 282 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 283 EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 284 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 285 EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 286 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 287 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 288 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 289 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 290 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 291 EUROPE: KEY MACROINDICATORS
- TABLE 292 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 293 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 294 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 295 GERMANY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 296 GERMANY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 297 GERMANY: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 298 GERMANY: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 299 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 300 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 301 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 302 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 303 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 304 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 305 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 306 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 307 UK: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 308 UK: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 309 UK: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 310 UK: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 311 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 312 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 313 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 314 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 315 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 316 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 317 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 318 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 319 FRANCE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 320 FRANCE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 321 FRANCE: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 322 FRANCE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 323 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 324 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 325 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 326 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 327 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 328 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 329 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 330 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 331 ITALY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 332 ITALY: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 333 ITALY: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 334 ITALY: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 335 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 336 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 337 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 338 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 339 ITALY: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 340 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 341 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 342 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 343 SPAIN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 344 SPAIN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 345 SPAIN: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 346 SPAIN: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 347 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 348 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 349 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 350 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 351 SPAIN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 352 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 353 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 354 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 355 REST OF EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 356 REST OF EUROPE: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 357 REST OF EUROPE: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 358 REST OF EUROPE: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 359 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 360 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 361 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 362 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 363 REST OF EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 364 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 365 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 366 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 367 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 368 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 369 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 370 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 371 ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 372 ASIA PACIFIC: SPATIAL GENOMICS MARKET PRODUCTS FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 373 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 374 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 375 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 376 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 377 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 378 ASIA PACIFIC: KEY MACROINDICATORS
- TABLE 379 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 380 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 381 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 382 CHINA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 383 CHINA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 384 CHINA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 385 CHINA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 386 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 387 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 388 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 389 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 390 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 391 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 392 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 393 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 394 JAPAN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 395 JAPAN: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 396 JAPAN: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 397 JAPAN: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 398 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 399 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 400 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 401 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 402 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 403 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 404 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 405 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 406 INDIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 407 INDIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 408 INDIA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 409 INDIA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 410 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 411 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 412 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 413 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 414 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 415 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 416 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 417 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 418 SOUTH KOREA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 419 SOUTH KOREA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 420 SOUTH KOREA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 421 SOUTH KOREA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 422 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 423 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 424 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 425 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 426 SOUTH KOREA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 427 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 428 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 429 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 430 AUSTRALIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 431 AUSTRALIA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 432 AUSTRALIA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 433 AUSTRALIA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 434 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 435 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 436 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 437 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 438 AUSTRALIA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 439 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 440 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 441 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 442 REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 443 REST OF ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 444 REST OF ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 445 REST OF ASIA PACIFIC: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 446 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 447 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 448 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 449 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 450 REST OF ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 451 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 452 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 453 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 454 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 455 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 456 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 457 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 458 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 459 LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 460 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 461 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 462 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 463 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 464 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 465 LATIN AMERICA: KEY MACROINDICATORS
- TABLE 466 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 467 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 468 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 469 BRAZIL: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 470 BRAZIL: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 471 BRAZIL: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 472 BRAZIL: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 473 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 474 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 475 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 476 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 477 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 478 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 479 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 480 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 481 MEXICO: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 482 MEXICO: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 483 MEXICO: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 484 MEXICO: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 485 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 486 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 487 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 488 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 489 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 490 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 491 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 492 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 493 REST OF LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 494 REST OF LATIN AMERICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 495 REST OF LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 496 REST OF LATIN AMERICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 497 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 498 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 499 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 500 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 501 REST OF LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 502 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 503 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 504 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 505 MIDDLE EAST: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 506 MIDDLE EAST: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 507 MIDDLE EAST: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 508 MIDDLE EAST: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 509 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 510 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 511 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 512 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 513 MIDDLE EAST: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 514 MIDDLE EAST: KEY MACROINDICATORS
- TABLE 515 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 516 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 517 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 518 AFRICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 519 AFRICA: SPATIAL TRANSCRIPTOMICS PRODUCTS MARKET FOR RNA SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 520 AFRICA: SPATIAL GENOMICS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 521 AFRICA: SPATIAL GENOMICS PRODUCTS MARKET FOR GENOMIC SEQUENCING, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 522 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 523 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 524 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 525 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 526 AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 527 AFRICA: KEY MACROINDICATORS
- TABLE 528 STRATEGIES ADOPTED BY KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2021-2024
- TABLE 529 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET: DEGREE OF COMPETITION
- TABLE 530 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: REGION FOOTPRINT
- TABLE 531 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: OFFERING FOOTPRINT
- TABLE 532 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: TECHNIQUE FOOTPRINT
- TABLE 533 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: APPLICATION FOOTPRINT
- TABLE 534 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: KEY STARTUPS/SMES
- TABLE 535 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
- TABLE 536 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
- TABLE 537 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DEALS, JANUARY 2021-NOVEMBER 2024
- TABLE 538 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: EXPANSIONS, JANUARY 2021-NOVEMBER 2024
- TABLE 539 10X GENOMICS: COMPANY OVERVIEW
- TABLE 540 10X GENOMICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 541 10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
- TABLE 542 10X GENOMICS: DEALS, JANUARY 2021-NOVEMBER 2024
- TABLE 543 10X GENOMICS: EXPANSIONS, JANUARY 2021-NOVEMBER 2024
- TABLE 544 BIO-TECHNE: COMPANY OVERVIEW
- TABLE 545 BIO-TECHNE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 546 BIO-TECHNE: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
- TABLE 547 BIO-TECHNE: DEALS, JANUARY 2021-NOVEMBER 2024
- TABLE 548 BIO-TECHNE: EXPANSIONS, JANUARY 2021-NOVEMBER 2024
- TABLE 549 NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.): COMPANY OVERVIEW
- TABLE 550 NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.): PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 551 NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.): PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
- TABLE 552 NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.): DEALS, JANUARY 2021-NOVEMBER 2024
- TABLE 553 STANDARD BIOTOOLS: COMPANY OVERVIEW
- TABLE 554 STANDARD BIOTOOLS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 555 STANDARD BIOTOOLS: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
- TABLE 556 STANDARD BIOTOOLS: DEALS, JANUARY 2021-NOVEMBER 2024
- TABLE 557 ILLUMINA, INC.: COMPANY OVERVIEW
- TABLE 558 ILLUMINA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 559 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
- TABLE 560 ILLUMINA, INC.: DEALS, JANUARY 2021-NOVEMBER 2024
- TABLE 561 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
- TABLE 562 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 563 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
- TABLE 564 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021-NOVEMBER 2024
- TABLE 565 AKOYA BIOSCIENCES, INC.: COMPANY OVERVIEW
- TABLE 566 AKOYA BIOSCIENCES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 567 AKOYA BIOSCIENCES, INC.: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
- TABLE 568 AKOYA BIOSCIENCES, INC.: DEALS, JANUARY 2021-NOVEMBER 2024
- TABLE 569 AKOYA BIOSCIENCES, INC.: EXPANSIONS, JANUARY 2021-NOVEMBER 2024
- TABLE 570 VISIOPHARM A/S: COMPANY OVERVIEW
- TABLE 571 VISIOPHARM A/S: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 572 VISIOPHARM A/S: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
- TABLE 573 VISIOPHARM A/S: DEALS, JANUARY 2021-NOVEMBER 2024
- TABLE 574 DANAHER CORPORATION: COMPANY OVERVIEW
- TABLE 575 DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 576 DANAHER CORPORATION: DEALS, JANUARY 2021-NOVEMBER 2024
- TABLE 577 SEVEN BRIDGES GENOMICS: COMPANY OVERVIEW
- TABLE 578 SEVEN BRIDGES GENOMICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 579 SEVEN BRIDGES GENOMICS: DEALS, JANUARY 2021-NOVEMBER 2024
- TABLE 580 REVVITY: COMPANY OVERVIEW
- TABLE 581 REVVITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 582 REVVITY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-NOVEMBER 2024
- TABLE 583 REVVITY: DEALS, JANUARY 2021-NOVEMBER 2024
- TABLE 584 VIZGEN INC.: COMPANY OVERVIEW
- TABLE 585 VIZGEN INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 586 VIZGEN INC.: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
- TABLE 587 VIZGEN INC.: DEALS, JANUARY 2021-NOVEMBER 2024
- TABLE 588 VERACYTE, INC.: COMPANY OVERVIEW
- TABLE 589 VERACYTE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 590 NATERA, INC.: COMPANY OVERVIEW
- TABLE 591 NATERA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 592 NATERA, INC.: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
- TABLE 593 NATERA, INC.: EXPANSIONS, JANUARY 2021-NOVEMBER 2024
- TABLE 594 MACROGEN INC.: COMPANY OVERVIEW
- TABLE 595 MACROGEN INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 596 MACROGEN, INC.: DEALS, JANUARY 2021-NOVEMBER 2024
- TABLE 597 MILTENYI BIOTEC: COMPANY OVERVIEW
- TABLE 598 MILTENYI BIOTEC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
- TABLE 599 MILTENYI BIOTEC: DEALS, JANUARY 2021-NOVEMBER 2024
- TABLE 600 BIOMARKER TECHNOLOGIES (BMKGENE): COMPANY OVERVIEW
- TABLE 601 ULTIVUE, INC: COMPANY OVERVIEW
- TABLE 602 RARECYTE, INC.: COMPANY OVERVIEW
- TABLE 603 S2 GENOMICS, INC.: COMPANY OVERVIEW
- TABLE 604 ADMERA HEALTH: COMPANY OVERVIEW
- TABLE 605 SONY BIOTECHNOLOGY INC.: COMPANY OVERVIEW
- TABLE 606 CANTATA BIO: COMPANY OVERVIEW
- TABLE 607 NUCLEAI, INC.: COMPANY OVERVIEW
- TABLE 608 VISIKOL, INC.: COMPANY OVERVIEW
- TABLE 609 IONPATH, INC.: COMPANY OVERVIEW
- TABLE 610 BIOSPYDER, INC.: COMPANY OVERVIEW
- TABLE 611 SINGULAR GENOMICS SYSTEMS, INC.: COMPANY OVERVIEW
- TABLE 612 LUNAPHORE TECHNOLOGIES SA.: COMPANY OVERVIEW
- TABLE 613 REBUS BIOSYSTEMS, INC.: COMPANY OVERVIEW
List of Figures
- FIGURE 1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: SEGMENTS AND REGIONS CONSIDERED
- FIGURE 2 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: YEARS CONSIDERED
- FIGURE 3 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: RESEARCH DESIGN
- FIGURE 4 BREAKDOWN OF PRIMARIES: BY RESPONDENT, DESIGNATION, AND REGION
- FIGURE 5 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
- FIGURE 6 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
- FIGURE 7 MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2023 (PRODUCTS MARKET)
- FIGURE 8 SERVICES MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (2023)
- FIGURE 9 PRODUCTS MARKET REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF ILLUMINA, INC. (2023)
- FIGURE 10 MARKET SIZE VALIDATION FROM PRIMARIES
- FIGURE 11 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH (PRODUCT)
- FIGURE 12 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET: CAGR PROJECTIONS (2024-2029)
- FIGURE 13 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET: CAGR PROJECTIONS (2024-2029)
- FIGURE 14 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET: DATA TRIANGULATION
- FIGURE 15 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
- FIGURE 16 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION)
- FIGURE 17 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
- FIGURE 18 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
- FIGURE 19 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
- FIGURE 20 SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
- FIGURE 21 SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET: REGIONAL SNAPSHOT
- FIGURE 22 HIGH R&D INVESTMENTS AND INCREASED FOCUS ON DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET
- FIGURE 23 CHINA AND SPATIAL TRANSCRIPTOMICS COMMANDED LARGEST MARKET SHARE IN 2023
- FIGURE 24 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
- FIGURE 25 ACADEMIC & RESEARCH INSTITUTES ACCOUNTED FOR LARGEST SHARE IN SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET 2023
- FIGURE 26 ACADEMIC & RESEARCH INSTITUTES ACCOUNTED FOR LARGEST SHARE IN SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET IN 2023
- FIGURE 27 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 28 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: TRENDS/ DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
- FIGURE 29 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2021-2023 (USD)
- FIGURE 30 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2021-2023 (USD)
- FIGURE 31 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2023 (USD)
- FIGURE 32 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2022 (USD)
- FIGURE 33 AVERAGE SELLING PRICE OF KEY PRODUCTS, BY REGION, 2021 (USD)
- FIGURE 34 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: SUPPLY CHAIN ANALYSIS
- FIGURE 35 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: VALUE CHAIN ANALYSIS
- FIGURE 36 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS
- FIGURE 37 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: NUMBER OF PATENT APPLICANTS/OWNERS IN LAST 10 YEARS (2014-2024)
- FIGURE 38 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 39 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
- FIGURE 40 KEY BUYING CRITERIA, BY END USER (PRODUCT)
- FIGURE 41 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: INVESTMENT & FUNDING SCENARIO, 2021-2023 (USD MILLION)
- FIGURE 42 IMPACT OF AI/GEN AI ON SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET
- FIGURE 43 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT
- FIGURE 44 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT
- FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, 2019-2023
- FIGURE 46 MARKET SHARE ANALYSIS OF SPATIAL GENOMICS & TRANSCRIPTOMICS PRODUCTS MARKET, 2023
- FIGURE 47 RANKING OF KEY PLAYERS IN SPATIAL GENOMICS & TRANSCRIPTOMICS SERVICES MARKET, 2023
- FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 49 EV/EBITDA OF KEY PLAYERS
- FIGURE 50 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
- FIGURE 51 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
- FIGURE 52 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY FOOTPRINT
- FIGURE 53 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
- FIGURE 54 10X GENOMICS: COMPANY SNAPSHOT
- FIGURE 55 BIO-TECHNE: COMPANY SNAPSHOT
- FIGURE 56 NANOSTRING TECHNOLOGIES, INC. (BRUKER SPATIAL BIOLOGY, INC.): COMPANY SNAPSHOT
- FIGURE 57 STANDARD BIOTOOLS: COMPANY SNAPSHOT
- FIGURE 58 ILLUMINA, INC.: COMPANY SNAPSHOT
- FIGURE 59 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
- FIGURE 60 AKOYA BIOSCIENCES, INC.: COMPANY SNAPSHOT
- FIGURE 61 DANAHER CORPORATION: COMPANY SNAPSHOT
- FIGURE 62 REVVITY: COMPANY SNAPSHOT
- FIGURE 63 NATERA, INC.: COMPANY SNAPSHOT
- FIGURE 64 MACROGEN INC.: COMPANY SNAPSHOT
02-2729-4219
+886-2-2729-4219
空間基因組學和轉錄組學市場：按產品類型、樣本類型、工作流程、應用、最終用戶和地區進行的全球分析和預測（2024-2034 年）
空間蛋白質體學市場 - 全球產業規模、佔有率、趨勢、機會和預測，按產品、技術、工作流程、樣本類型、最終用途、地區和競爭細分，2020-2030F
空間體學市場規模、佔有率、成長分析，按技術、按產品類型、按工作流程、按樣本類型、按最終用途、按地區 - 行業預測，2025 年至 2032 年
2030 年空間基因組學和轉錄組學市場預測：按產品、技術、應用、最終用戶和地區進行的全球分析
2030 年空間組學市場預測：按解決方案類型、樣本類型、工作流程、技術、應用、最終用戶和地區進行的全球分析
空間蛋白質體學市場規模、佔有率、趨勢分析報告：按產品、技術、工作流程、樣本類型、最終用途、地區和細分市場進行預測，2025 年至 2030 年
空間基因學和轉錄體學市場，規模，佔有率，趨勢，產業分析報告:各技術，各產品，各用途，各終端用戶，各地區:市場預測，2025年～2034年
空間基因組學和轉錄組學市場：按產品、技術和最終用戶分類 - 2025-2030 年全球預測
空間組學市場：按技術、樣本類型、產品、工作流程、最終用途 – 2025-2030 年全球預測
空間蛋白質體學市場、規模、佔有率、趨勢、行業分析報告：按產品、按技術、按工作流程、按樣本類型、按最終用途、按地區 - 市場預測，2024-2032 年
▼